Data for: Microporous Polysaccharide Hemosphere Efficacy and Safety in Primary Total Knee Arthroplasty
收藏相关数据集
Overview of included RRMS phase-3 trials (n = 13).
RRF = Rate of relapse free patients after 2 years, SE = Standard error, ARR = Annualized relapse rate over 2 years, SD = Standard deviation, 2001/2005 indicates the use of the original 2001 McDonald c
Figshare2015-12-02 更新50
Supplementary Material for: A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression
Introduction: In a multicenter, open-label, parallel-group, randomized, phase 2 study for pretreated advanced hepatocellular carcinoma (HCC), camrelizumab showed potent antitumor activity and acceptab
NIAID Data Ecosystem50
Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.
Association between the M-CHARTS score 12 months after initiating intravitreal ranibizumab therapy and baseline parameters in eyes with branch retinal vein occlusion.
Figshare2018-09-20 更新20
COR peak week 1 improvement and COR peak week 5 improvement.
Response and remission rates after 5 weeks of treatment in 40 depressed patients (sample 2) treated with either reboxetine (n = 20) or mirtazapine (n = 20) [33]. Patients are subdivided into COR peak
NIAID Data Ecosystem50
Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).
Quality health indicators achieved over the first 12 months of observation, stratified by treatment allocation (N = 818).
Figshare2022-11-02 更新30
